Raymond James Financial Services Advisors’s Medifast MED Stock Holding History

Raymond James Financial Services Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,107	Closed	-$872K	–	3358
2022 Q1	$872K	Sell	5,107 -2,973	-37%	-$560K	﹤0.01%	2047
2021 Q4	$1.69M	Buy	8,080 +3,250	+67%	+$672K	﹤0.01%	1646
2021 Q3	$930K	Buy	4,830 +1,381	+40%	+$339K	﹤0.01%	2009
2021 Q2	$976K	Buy	+3,449	New	+$935K	﹤0.01%	1957
2019 Q3	–	Sell	-2,743	Closed	-$352K	–	2892
2019 Q2	$352K	Buy	2,743 +221	+9%	+$30.7K	﹤0.01%	2164
2019 Q1	$322K	Buy	+2,522	New	+$320K	﹤0.01%	2186
2018 Q4	–	Sell	-3,605	Closed	-$799K	–	2719
2018 Q3	$799K	Buy	+3,605	New	+$731K	﹤0.01%	1608

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.46B AUM 71.13% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Raymond James Financial Services Advisors's MED Position: Q2 2022 in Review

Raymond James Financial Services Advisors sold out of Medifast (MED) in Q2 2022, closing a stake of 5,107 shares — an estimated $872K sold.

Raymond James Financial Services Advisors first reported a position in MED in Q3 2018 and held it in 7 quarters. The position peaked at $1.69M in Q4 2021. 284 funds tracked by Wall St. Rank hold MED as of Q2 2022.

Raymond James Financial Services Advisors reported no remaining Medifast position as of Q2 2022 after selling out during the quarter.
Raymond James Financial Services Advisors sold 5,107 Medifast shares in Q2 2022, an estimated $872K.
Raymond James Financial Services Advisors first reported a position in Medifast in Q3 2018 and held it in 7 quarters.
Raymond James Financial Services Advisors's Medifast position peaked at $1.69M in Q4 2021.
284 funds tracked by Wall St. Rank held Medifast as of Q2 2022.

Based on Raymond James Financial Services Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.